Double iterative optimisation for metabolic network-based drug target identification

International Journal of Data Mining and Bioinformatics

Volumn 3, Issue 2, 2009, Pages 124-144

  Song, Bin ^a   Sridhar, Padmavati ^a   Kahveci, Tamer ^a   Ranka, Sanjay ^a  

^a University of Florida   (United States)

Author keywords

Bioinformatics; Data mining; Drug target identification; Metabolic network

Indexed keywords

EID: 65549121278     PISSN: 17485673     EISSN: 17485681     Source Type: Journal    
DOI: 10.1504/IJDMB.2009.024847     Document Type: Article

References (34)

1. Arita, M. (2004) 'The metabolic world of Escherichia coli is not small', Proceedings of the National Academy of Sciences, Vol. 101, No. 6, pp.1543-1547.
2. Blandina, P., Cherici, G., Moroni, F., Prell, G.D. and Green, J.P. (1995) 'Release of glutamate from striatum of freely moving rats by pros-methylimidazoleacetic acid', Journal of Neurochemistry, Vol. 64, No. 2, pp.788-793.
3. Broder, S. and Venter, J.C. (2000) 'Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium', Annual Review of Pharmacology and Toxicology, Vol. 40, April, pp.97-132.
4. Chanda, S.K. and Caldwell, J.S. (2003) 'Fulfilling the promise: Drug discovery in the post-genomic era', Drug Discovery Today, Vol. 8, No. 4, February, pp.168-174.
5. Cornish-Bowden, A. (1986) 'Why is uncompetitive inhibition so rare?', FEBS Letters, Vol. 203, No. 1, July, pp.3-6.
6. Cornish-Bowden, A. and Cardenas, M.L. (2000) 'From genome to cellular phenotypea role for metabolic flux analysis?', Nature Biotechnology Vol. 18, pp.267-268.
7. Cornish-Bowden, A. and Hofmeyr, J.S. (2002) 'The role of stoichiometric analysis in studies of metabolism: An example', Journal of Theoretical Biology, Vol. 216, May, pp.179-191.
8. Davidov, E.J., Holland, J.M., Marple, E.W. and Naylor, S. (2003) 'Advancing drug discovery through systems biology', Drug Discovery Today, Vol. 8, No. 4, February, pp.175-183.
9. Deane, K.H.O., Spieker, S. and Clarke, C.E. (2004) 'Catechol-o-methyltransferase inhibitors versus active comparators for levodopa-induced complications in parkinson's disease', Cochrane Database of Systematic Reviews, Vol. 4. Art. No.: CD004553. DOI: 10.1002/14651858.CD004553.pub2
10. Drews, J. (2000) 'Drug discovery: A historical perspective', Science Vol. 287, No. 5460, March, pp.1960-1964.
11. Hatzimanikatis, V., Li, C., Ionita, J.A. and Broadbelt, L.J. (2004) 'Metabolic networks: Enzyme function and metabolite structure', Current Opinion in Structural Biology, Vol. 14, pp.300-306.
12. Imielinski, M., Belta, C., Halasz, A. and Rubin, H. (2005) 'Investigating metabolite essentiality through genome scale analysis of E. coli production capabilities', Bioinformatics, Vol. 21, No. 9, pp.2008-2016.
13. Imoto, S., Tamada, Y., Araki, H., Yasuda, K., Print, C.G., Charnock-Jones, S.D., Sanders, D., Savoie, C.J., Tashiro, K., Kuhara, S. and Miyano, S. (2006) 'Computational strategy for discovering druggable gene networks from genome-wide RNA expression profiles', Pacific Symposium on Biocomputing, Vol. 11, pp.559-571.
14. Jackson, L.K. and Phillips, M.A. (2002) 'Target validation for drug discovery in parasitic organisms', Current Topics in Medicinal Chemistry, Vol. 2, No. 5, May, pp.425-438.
15. Jeong, H., Oltvai, Z.N. and Barabasi, A. (2003) 'Prediction of protein essentiality based on genomic data', ComPlexUs, Vol. 1, pp.19-28.
16. Kanehisa, M. and Goto, S. (2000) 'KEGG: Kyoto encyclopedia of genes and genomes', Nucleic Acids Res., Vol. 28, No. 1, January, pp.27-30.
17. Klamt, S., Saez-Rodriguez, J., Lindquist, J.A., Simeoni, L. and Gilles, E.D. (2006) 'A methodology for the structural and functional analysis of signaling and regulatory networks', BMC Bioinformatics, Vol. 7, No. 56, DOI: 10.1186/1471-2105-7-56, http://www.biomedcentral.com/ 1471-2105/7/56
18. Lacroix, V., Fernandes, C.G. and Sagot, M-F. (2005) 'Reaction motifs in metabolic networks', 5th Workshop on Algorithms in Bioinformatics, pp.178-191.
19. Lemke, N., Herdia, F., Barcellos, C.K., dos Reis, A.N. and Mombach, J.C.M. (2004) 'Essentiality and damage in metabolic networks', Bioinformatics, Vol. 20, No. 1, January, pp.115-119.
20. Ma, H., Zhao, X., Yuan, Y. and Zeng, A. (2004) 'Decomposition of metabolic network into functional modules based on the global connectivity structure of reaction graph', Bioinformatics, Vol. 20, No. 12, pp.1870-1876.
21. Mombach, J.C., Lemke, N., da Silva, N.M., Ferreira, R.A., Isaia, E. and Barcellos, C.K. (2006) 'Bioinformatics analysis of mycoplasma metabolism: Important enzymes, metabolic similarities, and redundancy', Computers in Biology and Medicine, Vol. 36, No. 5, pp.542-552.
22. Nuttall, M.E. (2001) 'Drug discovery and target validation', Cells Tissues Organs., Vol. 169, No. 3, pp.265-271.
23. Prell, G.D., Khandelwal, J.K., Burns, R.S., Blandina, P., Morrishow, A.M. and Green, J.P. (1991) 'Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice', Journal of Neural Transmission, Vol. 3, No. 2, pp.1435-1463.
24. Rao, N.L., Dunford, P.J., Jiang, X., Lundeen, K.A., Coles, F., Riley, J.P., Williams, K.N., Grice, C.A., Edwards, J.P., Karlsson, L. and Fourie, A.M. (2007) 'Anti-inflammatory activity of a potent, selective leukotriene a4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton', Journal of Pharmacology and Experimental Therapeutics, Vol. 321, No. 3, pp.1154-1160.
25. Schuster, S., Fell, D.A. and Dandekar, T. (2000) 'A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks', Nature Biotechnology, Vol. 18, pp.326-332.
26. Smith, C. (2003) 'Hitting the target', Nature, Vol. 422, March, pp.341-347.
27. Sridhar, P., Kahveci, T. and Ranka, S. (2007) 'An iterative algorithm for metabolic network-based drug target identification', Pacific Symposium on Biocomputing, Vol. 12, pp.88-99.
28. Sridhar, P., Song, B., Kahveci, T. and Ranka, S. (2008) 'Mining metabolic networks for optimal drug targets', Pacific Symposium on Biocomputing, Vol. 13, pp.291-302.
29. Surtees, R. and Blau, N. (2000) 'The neurochemistry of phenylketonuria', European Journal of Pediatrics, Vol. 159, pp.109-113.
30. Takenaka, T. (2001) 'Classical vs. reverse pharmacology in drug discovery', British Journal of Urology International, Vol. 88, No. 2, September, pp.7-10.
31. Teichmann, S.A., Rison, S.C.G., Thornton, J.M., Riley, M., Gough, J. and Chothia, C. (2001) 'The evolution and structural anatomy of the small molecule metabolic pathways in Escherichia coli', Journal of Molecular Biology, Vol. 311, pp.693-708.
32. Terzer, M. and Stelling, J. (2006) 'Accelerating the computation of elementary modes using pattern trees', 6th Workshop on Algorithms in Bioinformatics, pp.333-343.
33. Torres-Galvan, M.J., Ortega, N., Sanchez-Garcia, F. and Blanco, C. (2001) 'LTC4-synthase A-444C polymorphism: Lack of association with NSAID-induced isolated periorbital angioedema in a Spanish population', Annals of Allergy Asthma and Immunology, Vol. 87, No. 6, pp.506-510.
34. Yeh, I., Hanekamp, T., Tsoka, S., Karp, P.D. and Altman, R.B. (2004) 'Computational analysis of Plasmodium falciparum metabolism: Organizing genomic information to facilitate drug discovery', Genome Research Vol. 14, pp.917-924.